Milestone Scientific, Inc. (MLSS) financial statements (2022 and earlier)

Company profile

Business Address 220 SOUTH ORANGE AVENUE
LIVINGSTON, NJ 07039
State of Incorp. DE
Fiscal Year End December 31
SIC 3842 - Orthopedic, Prosthetic, and Surgical Appliances and Supplies (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments14,76414,2241,5167432,6373,6024,194
Cash and cash equivalents14,76414,2241,5167432,6373,6024,194
Receivables9431,0811,7112,0783,7612,8861,794
Inventory, net of allowances, customer advances and progress billings1,5422,4201,6211,9213,3794,6034,258
Inventory1,5422,4201,6211,9213,3794,6034,258
Deferred costs   501,110620 
Advances on inventory purchases1,3094147116496977011,215
Other undisclosed current assets375416535415436302363
Total current assets:18,93418,5556,0935,85612,02012,71411,824
Noncurrent Assets
Operating lease, right-of-use asset551632 
Property, plant and equipment24314583142159236
Long-term investments and receivables    650  
Accounts and financing receivable, after allowance for credit loss    650  
Intangible assets, net (including goodwill)2783293824352,790660716
Intangible assets, net (excluding goodwill)2783293824352,790660716
Other noncurrent assets24243627271717
Other undisclosed noncurrent assets      16
Total noncurrent assets:8761,0174635453,608837985
TOTAL ASSETS:19,81019,5716,5566,40115,62913,55112,809
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2,1981,3072,1542,6873,2664,0133,644
Accounts payable7804831,3791,2059782,5762,088
Accrued liabilities1,4178247751,4822,2881,4361,556
Debt928416    
Due to related parties3963851,3591,664986  
Deferred revenue and credits1,7251,002 
Contract with customer, liability100
Other undisclosed current liabilities4959011,398422752  
Total current liabilities:3,0972,8784,9284,8736,7285,0143,644
Noncurrent Liabilities
Long-term debt and lease obligation497587     
Finance lease, liability2029 
Operating lease, liability477558 
Other undisclosed noncurrent liabilities(477)(558)  1,400  
Total noncurrent liabilities:497587  1,400  
Total liabilities:3,5943,4644,9284,8738,1285,0143,644
Stockholders' equity
Stockholders' equity attributable to parent, including:16,36816,2011,6961,5407,2448,50010,309
Preferred stock   000 
Common stock68644936353223
Treasury stock, value(912)(912)(912)(912)(912)(912)(912)
Additional paid in capital124,916117,93596,08288,41586,68982,76278,632
Accumulated deficit(107,704)(100,886)(93,524)(86,000)(78,568)(73,381)(67,435)
Other undisclosed stockholders' equity attributable to parent      0
Stockholders' equity attributable to noncontrolling interest(153)(94)(67)(11)25736(1,143)
Total stockholders' equity:16,21516,1071,6291,5287,5018,5369,165
TOTAL LIABILITIES AND EQUITY:19,81019,5716,5566,40115,62913,55112,809

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues10,3055,4378,3759,62211,28210,4829,492
Revenue, net11,28210,4829,492
Cost of revenue
(Cost of Goods and Services Sold)
(3,993)(1,816)(2,656)(5,191)(4,313)(4,176)(3,048)
Gross profit:6,3123,6215,7184,4316,9696,3066,443
Operating expenses(13,690)(11,074)(9,717)(12,431)(12,204)(12,820)(9,500)
Operating loss:(7,379)(7,453)(3,999)(7,999)(5,234)(6,514)(3,057)
Nonoperating income (expense) (25)(3,646)04(4)(2)
Investment income, nonoperating  (3,636)7914
Other nonoperating expense (25)(10)(7)(5)(5)(5)
Interest and debt expense276      
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes(16)72    
Loss from continuing operations before equity method investments, income taxes:(7,119)(7,471)(7,643)(7,999)(5,230)(6,518)(3,058)
Income (loss) from equity method investments2439881330(121)(796)(2,445)
Loss from continuing operations before income taxes:(6,876)(7,373)(7,562)(7,669)(5,350)(7,314)(5,504)
Income tax expense (benefit)(0)(16)(18)(24)(19)19(36)
Loss before gain (loss) on sale of properties:(6,876)(7,389)(7,580)(7,693)(5,370)(7,294)(5,540)
Other undisclosed net income   2   
Net loss:(6,876)(7,389)(7,580)(7,692)(5,370)(7,294)(5,540)
Net income attributable to noncontrolling interest5852562601831,34872
Net loss available to common stockholders, diluted:(6,818)(7,337)(7,524)(7,432)(5,187)(5,947)(5,468)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(6,876)(7,389)(7,580)(7,692)(5,370)(7,294)(5,540)
Comprehensive loss:(6,876)(7,389)(7,580)(7,692)(5,370)(7,294)(5,540)
Comprehensive income, net of tax, attributable to noncontrolling interest5852562601831,34872
Comprehensive loss, net of tax, attributable to parent:(6,818)(7,337)(7,524)(7,432)(5,187)(5,947)(5,468)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: